What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...
Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its patented semaglutide drugs exclusively. Compounding is the practice of ...
In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback